Cargando…
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977646/ https://www.ncbi.nlm.nih.gov/pubmed/27503238 http://dx.doi.org/10.1186/s40478-016-0352-1 |
_version_ | 1782447068011298816 |
---|---|
author | Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang |
author_facet | Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang |
author_sort | Metz, Imke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4977646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49776462016-08-10 Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang Acta Neuropathol Commun Letter to the Editor BioMed Central 2016-08-08 /pmc/articles/PMC4977646/ /pubmed/27503238 http://dx.doi.org/10.1186/s40478-016-0352-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
title | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
title_full | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
title_fullStr | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
title_full_unstemmed | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
title_short | Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
title_sort | disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977646/ https://www.ncbi.nlm.nih.gov/pubmed/27503238 http://dx.doi.org/10.1186/s40478-016-0352-1 |
work_keys_str_mv | AT metzimke disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis AT rieckmannpeter disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis AT kallmannborisalexander disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis AT bruckwolfgang disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis |